Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 21 | 2022 | 421 | 1.560 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 88 | 0.970 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2022 | 860 | 0.960 |
Why?
|
| Placenta | 4 | 2025 | 113 | 0.840 |
Why?
|
| Heart Rate | 3 | 2024 | 261 | 0.760 |
Why?
|
| Heart Defects, Congenital | 4 | 2025 | 72 | 0.730 |
Why?
|
| Obesity | 13 | 2021 | 1131 | 0.640 |
Why?
|
| Models, Statistical | 1 | 2021 | 190 | 0.630 |
Why?
|
| Genetic Loci | 7 | 2018 | 102 | 0.610 |
Why?
|
| Heart Diseases | 2 | 2018 | 110 | 0.600 |
Why?
|
| Body Mass Index | 13 | 2018 | 916 | 0.590 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 137 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 577 | 0.500 |
Why?
|
| Infant, Premature | 3 | 2025 | 134 | 0.490 |
Why?
|
| Blood Pressure | 2 | 2023 | 662 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 727 | 0.470 |
Why?
|
| Blood Glucose | 6 | 2019 | 386 | 0.470 |
Why?
|
| Cognition | 2 | 2018 | 458 | 0.450 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 972 | 0.450 |
Why?
|
| Hippocampus | 1 | 2018 | 591 | 0.440 |
Why?
|
| Humans | 53 | 2026 | 42163 | 0.440 |
Why?
|
| Brain | 4 | 2026 | 1452 | 0.430 |
Why?
|
| Infant, Newborn | 9 | 2026 | 960 | 0.420 |
Why?
|
| Energy Intake | 5 | 2025 | 162 | 0.410 |
Why?
|
| Female | 37 | 2026 | 24018 | 0.400 |
Why?
|
| Male | 34 | 2026 | 22779 | 0.370 |
Why?
|
| Genotype | 9 | 2018 | 796 | 0.360 |
Why?
|
| Insulin | 4 | 2015 | 255 | 0.350 |
Why?
|
| Survival Analysis | 3 | 2021 | 362 | 0.310 |
Why?
|
| DNA Methylation | 3 | 2025 | 393 | 0.310 |
Why?
|
| Dietary Proteins | 3 | 2014 | 35 | 0.310 |
Why?
|
| Exercise | 4 | 2022 | 674 | 0.310 |
Why?
|
| Phenotype | 7 | 2022 | 774 | 0.300 |
Why?
|
| Body Composition | 2 | 2019 | 160 | 0.290 |
Why?
|
| Pregnancy, High-Risk | 2 | 2025 | 8 | 0.290 |
Why?
|
| Aged | 17 | 2022 | 7982 | 0.270 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 729 | 0.260 |
Why?
|
| Aging | 2 | 2025 | 764 | 0.260 |
Why?
|
| Prospective Studies | 7 | 2026 | 1574 | 0.250 |
Why?
|
| Pregnancy in Diabetics | 1 | 2026 | 8 | 0.250 |
Why?
|
| Dietary Fats | 4 | 2014 | 117 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 274 | 0.240 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1020 | 0.240 |
Why?
|
| Parenteral Nutrition | 1 | 2025 | 15 | 0.230 |
Why?
|
| Aspartic Acid | 1 | 2025 | 51 | 0.230 |
Why?
|
| Diabetes, Gestational | 1 | 2026 | 55 | 0.230 |
Why?
|
| Soybean Oil | 1 | 2024 | 2 | 0.230 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2024 | 3 | 0.230 |
Why?
|
| Cerebellum | 1 | 2025 | 78 | 0.230 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2025 | 54 | 0.230 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2024 | 10 | 0.230 |
Why?
|
| Fetal Development | 1 | 2025 | 34 | 0.230 |
Why?
|
| Fish Oils | 1 | 2024 | 13 | 0.230 |
Why?
|
| Dietary Carbohydrates | 3 | 2014 | 34 | 0.230 |
Why?
|
| Heart Failure | 3 | 2018 | 298 | 0.220 |
Why?
|
| Birth Weight | 1 | 2025 | 94 | 0.220 |
Why?
|
| Middle Aged | 20 | 2022 | 11819 | 0.220 |
Why?
|
| Case-Control Studies | 6 | 2025 | 1266 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2025 | 300 | 0.200 |
Why?
|
| Transportation of Patients | 1 | 2022 | 15 | 0.190 |
Why?
|
| Pregnancy | 5 | 2026 | 1737 | 0.190 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2019 | 81 | 0.190 |
Why?
|
| Triglycerides | 3 | 2019 | 146 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 234 | 0.180 |
Why?
|
| Risk Factors | 8 | 2019 | 3942 | 0.180 |
Why?
|
| Adult | 15 | 2026 | 13458 | 0.180 |
Why?
|
| Body Height | 2 | 2013 | 53 | 0.180 |
Why?
|
| Insulin Resistance | 2 | 2015 | 199 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 146 | 0.180 |
Why?
|
| Patient Participation | 1 | 2022 | 87 | 0.180 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 20 | 0.170 |
Why?
|
| Gastric Bypass | 1 | 2021 | 22 | 0.170 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 512 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 249 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2021 | 121 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2803 | 0.160 |
Why?
|
| Overweight | 2 | 2019 | 248 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 138 | 0.160 |
Why?
|
| Intensive Care Units | 2 | 2017 | 71 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 36 | 0.160 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 66 | 0.160 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 18 | 0.150 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cohort Studies | 7 | 2018 | 1729 | 0.150 |
Why?
|
| Adiposity | 2 | 2017 | 155 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 404 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2018 | 44 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 285 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 75 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 14 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 18 | 0.140 |
Why?
|
| Seafood | 1 | 2017 | 24 | 0.140 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 281 | 0.130 |
Why?
|
| Critical Illness | 1 | 2017 | 46 | 0.130 |
Why?
|
| Alleles | 5 | 2016 | 352 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 90 | 0.130 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 11 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 62 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 192 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 164 | 0.120 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.120 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 5 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 17 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 88 | 0.120 |
Why?
|
| Meat | 1 | 2015 | 46 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2019 | 377 | 0.120 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.110 |
Why?
|
| Coffea | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 60 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 121 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 73 | 0.110 |
Why?
|
| Gestational Age | 2 | 2025 | 195 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2025 | 733 | 0.110 |
Why?
|
| Fasting | 2 | 2012 | 56 | 0.110 |
Why?
|
| Chromosome Mapping | 2 | 2012 | 198 | 0.110 |
Why?
|
| Hypertension | 1 | 2021 | 823 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1001 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2013 | 28 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 26 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2013 | 50 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 34 | 0.100 |
Why?
|
| Anthropometry | 1 | 2013 | 96 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 47 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2017 | 467 | 0.100 |
Why?
|
| Smoking | 2 | 2017 | 1019 | 0.100 |
Why?
|
| Magnesium | 1 | 2013 | 93 | 0.100 |
Why?
|
| Lung | 1 | 2015 | 484 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 75 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 138 | 0.090 |
Why?
|
| Waist-Hip Ratio | 3 | 2017 | 34 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2012 | 181 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 310 | 0.090 |
Why?
|
| Proteins | 1 | 2014 | 383 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2011 | 39 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 193 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 34 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 123 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 256 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 79 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 461 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 130 | 0.080 |
Why?
|
| Stem Cells | 1 | 2011 | 151 | 0.080 |
Why?
|
| Educational Status | 2 | 2022 | 335 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 428 | 0.070 |
Why?
|
| United States | 5 | 2018 | 5072 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3077 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2011 | 324 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 501 | 0.060 |
Why?
|
| Waist Circumference | 2 | 2017 | 90 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 810 | 0.060 |
Why?
|
| Genomics | 2 | 2018 | 289 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2026 | 27 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 725 | 0.060 |
Why?
|
| Sex Factors | 2 | 2019 | 1008 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2019 | 429 | 0.060 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 3 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2017 | 206 | 0.060 |
Why?
|
| Paraffin Embedding | 1 | 2024 | 13 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 2024 | 38 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2025 | 53 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2025 | 131 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 68 | 0.050 |
Why?
|
| Child Development | 1 | 2024 | 95 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2024 | 184 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 1139 | 0.050 |
Why?
|
| Prognosis | 2 | 2018 | 850 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 85 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.050 |
Why?
|
| Amyloid | 1 | 2023 | 66 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 93 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 311 | 0.050 |
Why?
|
| Memory | 1 | 2022 | 175 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 32 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 1597 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2019 | 93 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1066 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 27 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2018 | 103 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 114 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 180 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 26 | 0.030 |
Why?
|
| District of Columbia | 1 | 2017 | 73 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 438 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 263 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 680 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 107 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2016 | 7 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 353 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2016 | 83 | 0.030 |
Why?
|
| Residual Volume | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 231 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 61 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 188 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 431 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 20 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 548 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 63 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 203 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2485 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4936 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 34 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 5950 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 14 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 19 | 0.020 |
Why?
|
| Massachusetts | 1 | 2013 | 35 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 206 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 33 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1054 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 34 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 39 | 0.020 |
Why?
|
| Netherlands | 1 | 2012 | 12 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 97 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 99 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 25 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 146 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 224 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 58 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 157 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 136 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 140 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2013 | 164 | 0.020 |
Why?
|
| Life Style | 1 | 2013 | 326 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 222 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 318 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 47 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1051 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 355 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 242 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 358 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 557 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 845 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 744 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 6490 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 16695 | 0.010 |
Why?
|